Shandong Boan Biotechnology Co., Ltd. (HKG:6955)
Hong Kong · Delayed Price · Currency is HKD 4.640
-0.130 (-2.73%)
Jul 10, 2026, 9:44 AM HKT
HKG:6955 Market Cap
HKG:6955 has a market cap or net worth of 2.97 billion as of July 9, 2026. Its market cap has decreased by -60.48% in one year.
Market Cap
2.97B
Enterprise Value
2.58B
Revenue
873.36M
Ranking
n/a
PE Ratio
373.40
Stock Price
4.64
Market Cap Chart
Since December 30, 2022, HKG:6955's market cap has decreased from 10.08B to 2.97B, a decrease of -70.56%. That is a compound annual growth rate of -29.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.97B | -44.15% |
| Dec 31, 2025 | 5.31B | 6.29% |
| Dec 31, 2024 | 5.00B | -36.66% |
| Dec 29, 2023 | 7.89B | -21.72% |
| Dec 30, 2022 | 10.08B | - |
| Dec 30, 2022 | 10.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 4.02B |
| Jacobio Pharmaceuticals Group | 3.87B |
| Guangzhou Innogen Pharmaceutical Group | 3.76B |
| Qyuns Therapeutics | 3.74B |
| Mirxes Holding Company | 3.66B |
| Medtide | 3.14B |
| Jiangsu Recbio Technology | 3.08B |
| Laekna | 3.03B |